Choline C11 contrast

A Great Stride In PET Imaging, But Not A Panacea – C11 Choline For Diagnosing Recurrent Prostate Cancer

The FDA has approved c11 choline Injection, a Positron Emission Tomography (PET) imaging agent, for use in men to detect prostate cancer recurrences and to locate specific body sites for follow-up tissue sampling, testing and treatment. The indicated use for c11 choline injection is men with elevated prostate specific antigen (PSA) levels after earlier primary [...]

By Malecare|2012-09-14T13:07:20-04:00September 14th, 2012|Advanced Prostate Cancer, Bio Chemical Recurrence, Choline C11, Clinical Trials, Clinical Trials, FDA, salvage therapy, Uncategorized, Understanding APC|2 Comments

So Much Has Happened While I was Away – News About Advanced Prostate Cancer

The summer is coming to a close and I am back, ready to again take on the world. I had the fantastic opportunity of spending almost two weeks in Alaska, a land that is so different from the lower 48. I have to say that I have a new found respect for those individuals who [...]

By Malecare|2012-09-13T12:09:26-04:00September 13th, 2012|abiraterone acetate, Advanced Prostate Cancer, Alpharadin (radium-223), biomarkers, Bone Metastases, Choline C11, Drugs & Treatments, Early/Expanded Access Programs, enzalutamide, Enzalutamide (MDV-3100), General Information, MDV3100, Provenge, Uncategorized, Understanding APC, Xtandi|0 Comments